These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29774152)

  • 1. Acquisition of double mutation in
    Mori H; Suzuki H; Matsuzaki J; Masaoka T; Kanai T
    United European Gastroenterol J; 2018 Apr; 6(3):391-397. PubMed ID: 29774152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 10-Year Trends in Helicobacter pylori Eradication Rates by Sitafloxacin-Based Third-Line Rescue Therapy.
    Mori H; Suzuki H; Matsuzaki J; Masaoka T; Kanai T
    Digestion; 2020; 101(5):644-650. PubMed ID: 31387107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of 10-day Sitafloxacin-Containing Third-Line Rescue Therapies for Helicobacter pylori Strains Containing the gyrA Mutation.
    Mori H; Suzuki H; Matsuzaki J; Tsugawa H; Fukuhara S; Miyoshi S; Hirata K; Seino T; Matsushita M; Masaoka T; Kanai T
    Helicobacter; 2016 Aug; 21(4):286-94. PubMed ID: 26612407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic resistance and
    Mori H; Suzuki H; Matsuzaki J; Masaoka T; Kanai T
    United European Gastroenterol J; 2017 Oct; 5(6):796-804. PubMed ID: 29026593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations of Helicobacter pylori associated with fluoroquinolone resistance in Korea.
    Lee JW; Kim N; Nam RH; Park JH; Kim JM; Jung HC; Song IS
    Helicobacter; 2011 Aug; 16(4):301-10. PubMed ID: 21762270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoroquinolone resistance in Helicobacter pylori: role of mutations at position 87 and 91 of GyrA on the level of resistance and identification of a resistance conferring mutation in GyrB.
    Rimbara E; Noguchi N; Kawai T; Sasatsu M
    Helicobacter; 2012 Feb; 17(1):36-42. PubMed ID: 22221614
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Sue S; Sasaki T; Kaneko H; Irie K; Kondo M; Maeda S
    JGH Open; 2021 Feb; 5(2):307-311. PubMed ID: 33553672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Potential of Sitafloxacin as a New Drug Candidate for
    Choi YI; Lee SM; Chung JW; Kim KO; Kwon KA; Kim YJ; Kim JH; Lee SM; Jeong JY; Park DK
    Antibiotics (Basel); 2021 Oct; 10(10):. PubMed ID: 34680822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative eradication regimens for
    Miftahussurur M; Waskito LA; Syam AF; Nusi IA; Siregar G; Richardo M; Bakry AF; Rezkitha YAA; Wibawa IDN; Yamaoka Y
    Infect Drug Resist; 2019; 12():345-358. PubMed ID: 30774400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori eradication by sitafloxacin-lansoprazole combination and sitafloxacin pharmacokinetics in Mongolian gerbils and its in vitro activity and resistance development.
    Yamamoto T; Takano T; Higuchi W; Nishiyama A; Taneike I; Yoshida K; Kanda H; Imamura Y
    Antimicrob Agents Chemother; 2011 Sep; 55(9):4261-6. PubMed ID: 21730117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of a Novel Mutation in DNA Gyrase and Changes in the Fluoroquinolone Resistance of
    Rhie SY; Park JY; Shin TS; Kim JW; Kim BJ; Kim JG
    Antibiotics (Basel); 2020 May; 9(6):. PubMed ID: 32471292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sitafloxacin-based third-line rescue regimens for Helicobacter pylori infection in Japan.
    Furuta T; Sugimoto M; Kodaira C; Nishino M; Yamade M; Uotani T; Sahara S; Ichikawa H; Yamada T; Osawa S; Sugimoto K; Watanabe H; Umemura K
    J Gastroenterol Hepatol; 2014 Mar; 29(3):487-93. PubMed ID: 24224808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-center randomized controlled study to establish the standard third-line regimen for Helicobacter pylori eradication in Japan.
    Murakami K; Furuta T; Ando T; Nakajima T; Inui Y; Oshima T; Tomita T; Mabe K; Sasaki M; Suganuma T; Nomura H; Satoh K; Hori S; Inoue S; Tomokane T; Kudo M; Inaba T; Take S; Ohkusa T; Yamamoto S; Mizuno S; Kamoshida T; Amagai K; Iwamoto J; Miwa J; Kodama M; Okimoto T; Kato M; Asaka M;
    J Gastroenterol; 2013 Oct; 48(10):1128-35. PubMed ID: 23307042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sitafloxacin resistance in Helicobacter pylori isolates and sitafloxacin-based triple therapy as a third-line regimen in Japan.
    Hirata Y; Ohmae T; Yanai A; Sakitani K; Hayakawa Y; Yoshida S; Sugimoto T; Mitsuno Y; Akanuma M; Yamaji Y; Ogura K; Maeda S; Koike K
    Int J Antimicrob Agents; 2012 Apr; 39(4):352-5. PubMed ID: 22321702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary levofloxacin resistance and gyrA/B mutations among Helicobacter pylori in Japan.
    Miyachi H; Miki I; Aoyama N; Shirasaka D; Matsumoto Y; Toyoda M; Mitani T; Morita Y; Tamura T; Kinoshita S; Okano Y; Kumagai S; Kasuga M
    Helicobacter; 2006 Aug; 11(4):243-9. PubMed ID: 16882327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gatifloxacin resistance and mutations in gyra after unsuccessful Helicobacter pylori eradication in Japan.
    Nishizawa T; Suzuki H; Kurabayashi K; Masaoka T; Muraoka H; Mori M; Iwasaki E; Kobayashi I; Hibi T
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1538-40. PubMed ID: 16569878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vonoprazan-Based Third-Line Therapy Has a Higher Eradication Rate against Sitafloxacin-Resistant Helicobacter pylori.
    Saito Y; Konno K; Sato M; Nakano M; Kato Y; Saito H; Serizawa H
    Cancers (Basel); 2019 Jan; 11(1):. PubMed ID: 30669474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of gyrA mutations in fluoroquinolone-resistant Helicobacter pylori strains.
    Wang LH; Cheng H; Hu FL; Li J
    World J Gastroenterol; 2010 May; 16(18):2272-7. PubMed ID: 20458765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Four-times-daily Dosing of Rabeprazole with Sitafloxacin, High-Dose Amoxicillin, or Both for Metronidazole-Resistant Infection with Helicobacter pylori in Japan.
    Sugimoto M; Sahara S; Ichikawa H; Kagami T; Ban H; Otsuka T; Andoh A; Furuta T
    Helicobacter; 2017 Feb; 22(1):. PubMed ID: 27213463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights into resistance of Helicobacter pylori against third- and fourth-generation fluoroquinolones: A molecular docking study of prevalent GyrA mutations.
    Salehi N; Attaran B; Eskini N; Esmaeili M; Sharifirad A; Sadeghi M; Mohammadi M
    Helicobacter; 2019 Oct; 24(5):e12628. PubMed ID: 31282059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.